Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference40 articles.
1. Cancer of unknown primary (CUP)
2. Tumors of unknown origin
3. Development and Validation of a Prognostic Model to Predict the Length of Survival in Patients With Carcinomas of an Unknown Primary Site
4. Original article: Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site
5. Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Malignome unbekannter Primärlokalisation;Facharztwissen Hamatologie Onkologie;2024
2. Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial;Nature Communications;2023-10-24
3. Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary;Frontiers in Oncology;2023-07-10
4. Neoplasms of Unknown Primary Site;Holland‐Frei Cancer Medicine;2022-10-21
5. DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary;2022-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3